ConductScience.org, home

Paper12475985

Inhibition of cdk2 activating phosphorylation by mevastatin.

Ukomadu C and 1 other. J Biol Chem, 2003. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of cdk2 activating phosphorylation by mevastatin. Papers, record 12475985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12475985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of cdk2 activating phosphorylation by mevastatin.
PubMed
Journal
J Biol Chem
PubMed
Year
2003
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
0.82
iCite
Revised in PubMed
2021-12-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ukomadu CChinweike
2Dutta AAnindya

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anticholesteremic AgentsMajor topic
CDC2-CDC28 KinasesMajor topic
Cyclin-Dependent KinasesMajor topic
LovastatinMajor topic
Protein Serine-Threonine KinasesMajor topic
Cell Division
Cyclin-Dependent Kinase 2
Enzyme Activation
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Male
Phosphorylation
Prostatic Neoplasms
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01-CA89406NCI NIH HHSUnited StatesR01CA089406PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
40358525Cdk activation by phosphorylation: linking growth signals to cell cycle control.Biochem Soc Trans2025https://conductscience.org/library/papers/40358525PubMed
38893271Cholesterol Dietary Intake and Tumor Cell Homeostasis Drive Early Epithelial Tumorigenesis: A Potential Modelization of Early Prostate Tumorigenesis.Cancers (Basel)2024https://conductscience.org/library/papers/38893271PubMed
28130224CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer.Cancer Res2017https://conductscience.org/library/papers/28130224PubMed
26225745Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.Biochem Biophys Res Commun2015https://conductscience.org/library/papers/26225745PubMed
25916848RPA70 depletion induces hSSB1/2-INTS3 complex to initiate ATR signaling.Nucleic Acids Res2015https://conductscience.org/library/papers/25916848PubMed
24389535The strategies to control prostate cancer by chemoprevention approaches.Mutat Res2014https://conductscience.org/library/papers/24389535PubMed
23483972Targeted deletion of fibrinogen like protein 1 reveals a novel role in energy substrate utilization.PLoS One2013https://conductscience.org/library/papers/23483972PubMed
22072796UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis.Mol Biol Cell2012https://conductscience.org/library/papers/22072796PubMed
21214517UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis.Biochem J2011https://conductscience.org/library/papers/21214517PubMed
20190811Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells.Oncogene2010https://conductscience.org/library/papers/20190811PubMed
18947424The prince and the pauper. A tale of anticancer targeted agents.Mol Cancer2008https://conductscience.org/library/papers/18947424PubMed
18679777Simvastatin inducing PC3 prostate cancer cell necrosis mediated by calcineurin and mitochondrial dysfunction.J Bioenerg Biomembr2008https://conductscience.org/library/papers/18679777PubMed
17092340Regulation of CDK4.Cell Div2006https://conductscience.org/library/papers/17092340PubMed
16782892Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".Mol Cell Biol2006https://conductscience.org/library/papers/16782892PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDK21017PubTator's text mininghttps://conductscience.org/library/genes/1017NCBI Gene
CDK71022PubTator's text mininghttps://conductscience.org/library/genes/1022NCBI Gene
CDKN1C1028PubTator's text mininghttps://conductscience.org/library/genes/1028NCBI Gene
DCTN610671PubTator's text mininghttps://conductscience.org/library/genes/10671NCBI Gene
H3P16644914PubTator's text mininghttps://conductscience.org/library/genes/644914NCBI Gene
MNAT14331PubTator's text mininghttps://conductscience.org/library/genes/4331NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12475985

GET https://conductscience.org/api/papers/v1/12475985/authors